Brief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
24/06/2024 12:16
June 24 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS - EXPECTS TO INCUR ONE-TIME CHARGES
AND
CASH EXPENDITURES ASSOCIATED WITH WORKFORCE REDUCTION OF ABOUT
$0.6 MILLION
* EFFECTOR THERAPEUTICS INC - EXPECTS THAT THE CHARGES AND
COSTS
WILL BE INCURRED DURING QUARTER ENDED JUNE 30, 2024
Source text for Eikon: ID:n0001193125-24-166275
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright